Edan Instruments

Edan Instruments Payout Ratio

The Dividend Payout Ratio of Edan Instruments (300206.SZ) as of Oct 27, 2026 is 39.28 %. In the previous year, Dividend Payout Ratio was 74.01 % — a change of -46.93% (lower).

Payout Ratio

39.28 %

YoY

-46.93%

Last updated:

Dividend Payout Ratio of Edan Instruments is 2025 39.28 % . Dividend Payout Ratio of Edan Instruments was 2024 74.01 % . It decreases by -46.93% lower compared to the previous year.

The payout ratio is around 39% of earnings.

The Edan Instruments Payout Ratio history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Payout Ratio
Date
Payout Ratio
Jan 1, 2021
108.67 CNY
Jan 1, 2022
51.05 CNY
Jan 1, 2023
54.19 CNY
Jan 1, 2024
74.01 CNY
Jan 1, 2025
39.28 CNY
Jan 1, 2026 (e)
48.59 CNY
Jan 1, 2027 (e)
42.03 CNY
Jan 1, 2028 (e)
37.02 CNY
The Edan Instruments Payout Ratio history
YEARPayout RatioYoY
est37.02 %-11.90%
est42.03 %-13.51%
est48.59 %+23.72%
39.28 %-46.93%
74.01 %+36.58%
54.19 %+6.14%
51.05 %-53.02%
108.67 %+609.44%
15.32 %-66.35%
45.52 %-15.14%
53.64 %+17.88%
45.50 %-75.72%
187.42 %+892.95%
18.87 %-90.88%
206.92 %+147.87%
83.48 %+129.28%
36.41 %+39.15%
26.17 %-53.13%
55.83 %0.00%
55.83 %0.00%
55.83 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Edan Instruments Stock analysis

What does Edan Instruments do? Edan Instruments, Inc. generates revenue through the design, manufacture, and sale of medical equipment, including maternity product series like doppler fetal heart beat monitors, ultrasonic doppler fetal heart beat monitors, fetal/maternal monitors, and maternity integrated diagnostic monitoring systems. The company also sells electrocardiograph series such as digital twelve-channel electrocardiographs, digital six-channel electrocardiographs, and electrocardiographic workstations, along with monitoring products like portable multi-variable monitors and central monitoring systems. Additionally, Edan offers spare parts and in vitro diagnostics products to support its equipment and medical services. The primary buyers of Edan's products are healthcare institutions, including hospitals and clinics, which purchase medical devices for diagnostic and monitoring purposes. These institutions rely on Edan's maternity, electrocardiograph, and monitoring systems to provide patient care. The company's in vitro diagnostics products are also sold to medical facilities for laboratory testing needs. Edan's product segments are defined by medical equipment categories: maternity, electrocardiograph, monitoring, and ultrasonic image systems. The spare parts and in vitro diagnostics businesses complement these segments by providing essential accessories and diagnostic tools. Revenue is derived from direct sales of these products to healthcare providers, with no mention of third-party distribution or additional services beyond the described offerings. Edan Instruments is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Edan Instruments stock

Dividend Payout Ratio of Edan Instruments is 39.28 % in 2025.

Dividend Payout Ratio of Edan Instruments changed from 74.01 % to 39.28 %, representing a -46.93% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Dividend Payout Ratio Edan Instruments since 2006 – with annual values, charts, and detailed analysis.

The payout ratio measures the percentage of net income distributed as dividends. A sustainable payout ratio leaves room for reinvestment and growth.

Dividend Payout Ratio's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Dividend Payout Ratio's Edan Instruments historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Edan Instruments

All Key Metrics — Edan Instruments